Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na+-pump activity
- PMID: 6286476
- DOI: 10.1161/01.hyp.4.5.575
Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na+-pump activity
Abstract
We studied the effects of anteroventral third ventricle (AV3V) lesions on the vascular Na+-pump activity of deoxycorticosterone acetate-salt (DOCA-salt) treated rats. Blood pressures and Na+-pump activity of the isolated tail arteries, measured as ouabain-sensitive 86Rb-uptake, were determined in untreated control rats, DOCA-salt treated rats, rats with AV3V lesions, and rats with AV3V lesions which were treated with DOCA-salt. Control rats receiving DOCA treatment developed higher blood pressures than rats receiving no DOCA treatment. Placement of AV3V lesions prior to administration of DOCA prevented the increase in blood pressure. Vascular Na+-pump activity in the DOCA-treated group was reduced by 20% compared to all other groups. The AV3V lesions prevented the suppression of Na+-pump activity caused by DOCA treatment. Suppression of vascular Na+-pump activity was due to a humoral substance since Na+-pump activity of tail arteries from control rats incubated in plasma from DOCA-salt treated rats was suppressed by 25% when compared to those incubated in control plasma. Our findings support the hypothesis that a circulating pressor substance is at least partially responsible for the development of DOCA-salt hypertension and that the mechanism by which AV3V lesions prevent DOCA hypertension may be through the interruption of secretion, transport, or synthesis of this factor.
Similar articles
-
Effect of DOCA-salt treatment duration and anteroventral third ventricle lesions on a plasma-borne sodium pump inhibitor in rats.J Hypertens. 1987 Aug;5(4):461-7. J Hypertens. 1987. PMID: 3668248
-
Effect of anteroventral third ventricle lesions on vascular sodium-pump activity in two-kidney Goldblatt hypertension.Hypertension. 1983 Mar-Apr;5(2 Pt 2):I89-93. doi: 10.1161/01.hyp.5.2_pt_2.i89. Hypertension. 1983. PMID: 6298107
-
Vasopressin-central nervous system interactions in the development of DOCA hypertension.Hypertension. 1982 May-Jun;4(3 Pt 2):131-7. Hypertension. 1982. PMID: 7068203
-
Sodium pump activity and calcium relaxation in vascular smooth muscle of deoxycorticosterone acetate-salt rats.Hypertension. 1986 Nov;8(11):1032-9. doi: 10.1161/01.hyp.8.11.1032. Hypertension. 1986. PMID: 2429928
-
The sodium-potassium pump in volume expanded hypertension.Clin Exp Hypertens (1978). 1978-1979;1(3):295-336. doi: 10.3109/10641967809068611. Clin Exp Hypertens (1978). 1978. PMID: 387359 Review.
Cited by
-
Central neuromodulatory pathways regulating sympathetic activity in hypertension.J Appl Physiol (1985). 2012 Oct 15;113(8):1294-303. doi: 10.1152/japplphysiol.00553.2012. Epub 2012 Jul 5. J Appl Physiol (1985). 2012. PMID: 22773773 Free PMC article. Review.
-
The organum vasculosum of the lamina terminalis contributes to neurohumoral mechanisms of renal vascular hypertension.Am J Physiol Regul Integr Comp Physiol. 2025 Feb 1;328(2):R161-R171. doi: 10.1152/ajpregu.00203.2024. Epub 2024 Dec 20. Am J Physiol Regul Integr Comp Physiol. 2025. PMID: 39705721 Free PMC article.
-
Digitalislike circulating factor in hypertension: potential messenger between salt balance and intracellular sodium.Cardiovasc Drugs Ther. 1990 Mar;4 Suppl 2:343-9. doi: 10.1007/BF02603174. Cardiovasc Drugs Ther. 1990. PMID: 2176807 Review.
-
Role of mineralocorticoid action in the brain in salt-sensitive hypertension.Clin Exp Pharmacol Physiol. 2012 Jan;39(1):90-5. doi: 10.1111/j.1440-1681.2011.05538.x. Clin Exp Pharmacol Physiol. 2012. PMID: 21585422 Free PMC article. Review.
-
Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.Adv Chronic Kidney Dis. 2015 May;22(3):232-44. doi: 10.1053/j.ackd.2014.12.005. Adv Chronic Kidney Dis. 2015. PMID: 25908473 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical